Stryker names Spencer Stiles CEO as RBC keeps Buy on Stryker stock
Published on 10/06/2026 at 16:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Stryker (ISIN US8636671013) announced on October 6, 2026 that Spencer Stiles will become chief executive officer on January 1, 2027, replacing Kevin Lobo, who will move to executive chair. The leadership change arrives as Markets Insider reported on October 2, 2026 that RBC Capital maintained a Buy rating and a USD 420.00 price target.
Internal succession takes shape
According to Stryker on October 6, 2026, Stiles will also join the board when he takes the CEO role. He has served as president and chief operating officer since January 2026 and has spent 27 years at the company across Orthopaedics, MedSurg and Neurotechnology.
The board will expand from 10 to 11 members. Lobo will remain chief executive through December 31, 2026, giving the company almost three months to manage the handover before the new structure takes effect.
Results provide the financial baseline
Stryker reported USD 6.59 billion of revenue in the second quarter of 2026, compared with USD 6.02 billion in the second quarter of 2025, an increase of 9.47 percent. Net profit rose to USD 1.28 billion from USD 884.00 million over the same periods, an increase of 44.80 percent, according to Markets Insider.
The company narrowed its full-year 2026 outlook to organic net sales growth of 8.30 percent to 9.30 percent and adjusted earnings per share of USD 14.95 to USD 15.10, as reported in the second-quarter call transcript by Fortune. The leadership transition therefore comes against a recovery plan that still depends on production execution and the resolution of supply disruption in Peripheral Vascular.
Results date and stock context
Stryker has scheduled its third-quarter 2026 financial results for October 29, 2026, with the release planned for 4:05 p.m. ET and the webcast at 4:30 p.m. ET, according to GlobeNewswire. The latest structured quote placed Stryker at USD 281.69 on the NYSE at 10:43 a.m. ET on October 6, 2026, versus a 52-week range of USD 267.00 to USD 392.55; the price stood 28.24 percent below the high.
Stryker stock was last at EUR 246.50 on Tradegate on October 5, 2026 at 2:36 p.m. CEST. Price source: substitute price Tradegate, Lang & Schwarz without data set.
Stryker Corporation key facts
- Company: Stryker Corporation
- ISIN: US8636671013
- Ticker: SYK
- Primary exchange: NYSE
- Substitute price Tradegate (as of October 5, 2026, 2:36 p.m. CEST): EUR 246.50
- Market capitalization: USD 108.0 billion (as of October 6, 2026)
- 52-week range: USD 267.00-392.55 (as of October 6, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: October 29, 2026
More news and analyses on Stryker stock.
